151
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Mangifera zeylanica and Mangifera indica Leaf Extracts Exert Anticancer Effects Possibly by Inhibiting Histone Deacetylases

, ORCID Icon, ORCID Icon, , , & show all
Pages 98-113 | Received 07 Jun 2022, Published online: 06 Sep 2022

References

  • Siegel, R. L.; Miller, K. D.; Fuchs, H. E.; Jemal, A. Cancer Statistics, 2021. CA: Cancer J. Clin. 2021, 71(1), 7–33. DOI: 10.3322/caac.21654.
  • Sung, H.; Ferlay, J.; Siegel, R. L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: Cancer J. Clin. 2021, 71(3), 209–249. DOI: 10.3322/caac.21660.
  • Takiar, R.; Kumar, S. Pattern of Reproductive Cancers in India. APJCP. 2014, 15(2), 599–603. DOI: 10.7314/apjcp.2014.15.2.599.
  • Dela Cruz, C. S.; Tanoue, L. T.; Matthay, R. A. Lung Cancer: epidemiology, Etiology, and Prevention. Clin. Chest Med. 2011, 32(4), 605–644. DOI: 10.1016/j.ccm.2011.09.001.
  • Toh, C. K.; Gao, F.; Lim, W. T.; Leong, S. S.; Fong, K. W.; Yap, S. P.; Hsu, A. A. L.; Eng, P.; Koong, H.-N.; Thirugnanam, A., et al. Differences between Small-Cell Lung Cancer and Non-Small-Cell Lung Cancer among Tobacco Smokers. Lung Cancer. 2007, 56(2), 161–166. DOI: 10.1016/j.lungcan.2006.12.016.
  • Hammerschmidt, S.; Wirtz, H. Lung Cancer: current Diagnosis and Treatment. Dtsch. Ärztebl. int. 2009, 106(49), 809–818. quiz 819–20. DOI: 10.3238/arztebl.2009.0809.
  • Lowenthal, R. M.; Eaton, K. Toxicity of Chemotherapy. Hematol. Oncol. Clin. North Am. 1996, 10(4), 967–990. DOI: 10.1016/s0889-8588(05)70378-6.
  • Cragg, G. M.; Newman, D. J. Plants as a Source of Anti-Cancer Agents. J. Ethnopharmacol. 2005, 100(1–2), 72–79. DOI: 10.1016/j.jep.2005.05.011.
  • Rayan, A.; Jamal, R.; Falah, M. Nature Is the Best Source of Anticancer Drugs: indexing Natural Products for Their Anticancer Bioactivity. PloS One. 2017, 12(11), e0187925. DOI: 10.1371/journal.pone.0187925.
  • Bhanot, A.; Bhanot, R., and Malleshappa, N . Natural Sources As Potential Anti-Cancer Agents: a Review. Int. J. Phytomedicine. 2011 jun 19;3(1), 9–26.
  • Ediriweera, M. K.; Thabrew, I.; De Silva, E. D. E: a Study of the Potential Anticancer Activity of Mangifera Zeylanica Bark: evaluation of Cytotoxic and Apoptotic Effects of the Hexane Extract and Bioassay-Guided Fractionation to Identify Phytochemical Constituents. Oncol. Lett. 2016a, 11, 1335–1344. DOI: 10.3892/ol.2016.4087.
  • Ediriweera, M. K.; Tennekoon, K. H.; Samarakoon, S. R.; Adhikari, A.; Thabrew, I.; de Silva, E. D. Isolation of a New Resorcinolic Lipid from Mangifera Zeylanica Hook.f. Bark and Its Cytotoxic and Apoptotic Potential. Biomed. Pharmacother. 2017b, 89, 194–200. DOI: 10.1016/j.biopha.2017.01.176.
  • Ediriweera, M. K.; Tennekoon, K. H.; Adhikari, A.; Samarakoon, S. R.; Thabrew, I.; de Silva, E. D. New Halogenated Constituents from Mangifera Zeylanica Hook.f. and Their Potential Anti-Cancer Effects in Breast and Ovarian Cancer Cells. J.Ethnopharmacol. 2016b, 189, 165–174. DOI: 10.1016/j.jep.2016.05.047.
  • Ediriweera, M. K.; Tennekoon, K. H.; Samarakoon, S. R.; Thabrew, I.; De Silva, E. D. Induction of Apoptosis in MCF-7 Breast Cancer Cells by Sri Lankan Endemic Mango (Mangifera Zeylanica) Fruit Peel through Oxidative Stress and Analysis of Its Phytochemical Constituents: anticancer Effects of Mangifera Zeylanica Peel. J. Food Biochem. 2017c, 41(1), e12294. DOI: 10.1111/jfbc.12294.
  • Shah, K. A.; Patel, M. B.; Patel, R. J.; Parmar, P. K. Mangifera indica (Mango). Pharmacogn. Rev. 2010, 4(7), 42–48. DOI: 10.4103/0973-7847.65325.
  • Ediriweera, M. K.; Tennekoon, K. H. SR:A Review on Ethnopharmacological Applications, Pharmacological Activities, and Bioactive Compounds of Mangifera Indica(Mango). ECAM. 2017a, 2017, 1–24.
  • Selvakumar, I.; Vasudevan, A.; Perera, N.; Ediriweera, M. K.; Nagarajan, D.; Samarakoon, S. R.; Tennekoon, K. H.; Vellingiri, V. Mangifera Indica and Mangifera Zeylanica: perspectives on Medicinal Properties, Therapeutic Applications and Potential Uses as Anticancer Epigenetic Drugs (Review). Int. J. Epigenet. 2022, 2(1), 1. DOI: 10.3892/ije.2022.10.
  • Kedare, S. B.; Singh, R. P. Genesis and Development of DPPH Method of Antioxidant Assay. J. Food Sci. Technol. 2011, 48(4), 412–422. DOI: 10.1007/s13197-011-0251-1.
  • Hulkower, K. I.; Herber, R. L. Cell Migration and Invasion Assays as Tools for Drug Discovery. Pharmaceutics. 2011, 3, 107–124. DOI: 10.3390/pharmaceutics3010107.
  • Nivedha, K.; Sivasakthi, S.; Prakash, A.; Devipriya, N.; Vadivel, V. In Vitro Studies on Antioxidant and Cyto-Protective Activities of Polyphenol-Rich Fraction Isolated from Mangifera Indica Leaf. S. Afr. J. Bot. 2020, 130, 396–406. DOI: 10.1016/j.sajb.2020.01.019.
  • Rasul, A.; Riaz, A.; Wei, W.; Sarfraz, I.; Hassan, M.; Li, J.; Asif, F.; Adem, Ş.; Bukhari, S. A.; Asrar, M., et al. Mangifera Indica Extracts as Novel PKM2 Inhibitors for Treatment of Triple Negative Breast Cancer. BioMed. Res. Int. 2021, 2021, 5514669. DOI: 10.1155/2021/5514669.
  • Mohan, C. G.; Deepak, M.; Viswanatha, G. L.; Savinay, G.; Hanumantharaju, V.; Rajendra, C. E.; Praveen, D. H. Anti-Oxidant and Anti-Inflammatory Activity of Leaf Extracts and Fractions of Mangifera Indica. Asian Pac. J. Trop. Med. 2013, 6(4), 311–314. DOI: 10.1016/s1995-7645(13)60062-0.
  • Hassan, M.; Watari, H.; AbuAlmaaty, A.; Ohba, Y.; Sakuragi, N. Apoptosis and Molecular Targeting Therapy in Cancer. Bio Med Res.Int. 2014, 2014, 150845. DOI: 10.1155/2014/150845.
  • Loreto, C.; Rocca, G. L.; Anzalone, R.; Caltabiano, R.; Vespasiani, G.; Castorina, S.; Ralph, D. J.; Cellek, S.; Musumeci, G.; Giunta, S., et al. The Role of Intrinsic Pathway in Apoptosis Activation and Progression in Peyronie’s Disease. BioMed. Res. Int. 2014, 2014, 616149. DOI: 10.1155/2014/616149.
  • Nair, P.; Lu, M.; Petersen, S.; Ashkenazi, A. Apoptosis Initiation through the Cell-Extrinsic Pathway. Meth. Enzymol. 2014, 544, 99–128. DOI: 10.1016/B978-0-12-417158-9.00005-4.
  • McIlwain, D. R.; Berger, T.; Mak, T. W. Caspase Functions in Cell Death and Disease. Cold Spring Harb. Perspect. Biol. 2015, 7(4), a026716. DOI: 10.1101/cshperspect.a026716.
  • Ozaki, T.; Nakagawara, A. P53: the Attractive Tumor Suppressor in the Cancer Research Field. J.Biomed.Biotechnol. 2011, 2011, 603925. DOI: 10.1155/2011/603925.
  • Kholoussi, N. M.; El-Nabi, S. E. H.; Esmaiel, N. N.; Abd El-Bary, N. M.; El-Kased, A. F. Evaluation of Bax and Bak Gene Mutations and Expression in Breast Cancer. BioMed. Res. Int. 2014, 2014, 249372. DOI: 10.1155/2014/249372.
  • Große, L.; Wurm, C. A.; Brüser, C.; Neumann, D.; Jans, D. C.; Jakobs, S. Bax Assembles into Large Ring-like Structures Remodeling the Mitochondrial Outer Membrane in Apoptosis. EMBO J. 2016, 35(4), 402–413. DOI: 10.15252/embj.201592789.
  • Jaiswal, P. K.; Goel, A.; Mittal, R. D. Survivin: a Molecular Biomarker in Cancer. Indian J. Med. Res. 2015, 141(4), 389–397. DOI: 10.4103/0971-5916.159250.
  • Chandele, A.; Prasad, V.; Jagtap, V. J. C.; Shukla, R.; Shastry, P. R. Upregulation of Survivin in G2/M Cells and Inhibition of Caspase 9 Activity Enhances Resistance in Staurosporine-Induced Apoptosis. Neoplasia (New York, N.Y.). 2004, 6(1), 29–40. DOI: 10.1016/s1476-5586(04)80051-4.
  • Li, G.; Tian, Y.; Zhu, W. G. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy. Front. Cell Dev. Biol. 2020, 8, 576946. DOI: 10.3389/fcell.2020.576946.
  • Pant, K.; Peixoto, E.; Richard, S.; Gradilone, S. A. Role of Histone Deacetylases in Carcinogenesis: potential Role in Cholangiocarcinoma. Cells (Basel, Switzerland). 2020, 9(3), 780. DOI: 10.3390/cells9030780.
  • Imran, M.; Arshad, M. S.; Butt, M. S.; Kwon, J. H.; Arshad, M. U.; Sultan, M. T. Mangiferin: a Natural Miracle Bioactive Compound against Lifestyle Related Disorders. Lipids Health Dis. 16, 20171 DOI:10.1186/s12944-017-0449-y.
  • Li, M.; Ma, H.; Yang, L.; Li, P. Mangiferin Inhibition of Proliferation and Induction of Apoptosis in Human Prostate Cancer Cells Is Correlated with Downregulation of B-Cell Lymphoma-2 and Upregulation of MicroRNA-182. Oncol. Lett. 2016, 11(1), 817–822. DOI: 10.3892/ol.2015.3924.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.